XTL Biopharmaceuticals Ltd (XTLB)
2.693
+0.04
(+1.62%)
USD |
NASDAQ |
May 17, 16:00
2.71
+0.02
(+0.63%)
After-Hours: 20:00
XTL Biopharmaceuticals Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2014 | -0.674M |
September 30, 2014 | -0.455M |
June 30, 2014 | -0.544M |
March 31, 2014 | -0.797M |
December 31, 2013 | -0.52M |
September 30, 2013 | -0.758M |
June 30, 2013 | -0.668M |
March 31, 2013 | -0.553M |
December 31, 2012 | -0.408M |
September 30, 2012 | -0.471M |
June 30, 2012 | -0.344M |
March 31, 2012 | -0.283M |
Date | Value |
---|---|
December 31, 2011 | 0.228M |
September 30, 2011 | -0.246M |
June 30, 2011 | -0.885M |
March 31, 2011 | -0.409M |
September 30, 2010 | -0.209M |
June 30, 2010 | -0.109M |
March 31, 2010 | -0.135M |
December 31, 2009 | -0.228M |
September 30, 2009 | -0.235M |
June 30, 2009 | -0.114M |
March 31, 2009 | -1.911M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
Compugen Ltd | -- |
Pluri Inc | -4.202M |
BioLine Rx Ltd | 4.991M |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -6.242M |
Cash from Operations (Quarterly) Related Metrics
Free Cash Flow Yield | -16.90% |